nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP11B2—Spironolactone—dilated cardiomyopathy	0.594	0.606	CbGbCtD
Metyrapone—CYP11B1—Spironolactone—dilated cardiomyopathy	0.386	0.394	CbGbCtD
Metyrapone—Niacin—SLC22A5—dilated cardiomyopathy	0.00459	1	CrCbGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00303	0.228	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00236	0.177	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00127	0.0957	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00109	0.0816	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000979	0.0736	CbGpPWpGaD
Metyrapone—ABCC3—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000746	0.0561	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000689	0.0518	CbGpPWpGaD
Metyrapone—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.000214	0.0892	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.000211	0.0159	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000205	0.0154	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000193	0.0145	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000177	0.0133	CbGpPWpGaD
Metyrapone—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000174	0.0726	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000166	0.0125	CbGpPWpGaD
Metyrapone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000157	0.0655	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000127	0.00956	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00012	0.00899	CbGpPWpGaD
Metyrapone—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000112	0.00841	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000109	0.0454	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000107	0.00802	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ANKRD1—dilated cardiomyopathy	9.13e-05	0.00686	CbGpPWpGaD
Metyrapone—Angiopathy—Furosemide—dilated cardiomyopathy	8.76e-05	0.0366	CcSEcCtD
Metyrapone—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.62e-05	0.00648	CbGpPWpGaD
Metyrapone—Pancytopenia—Lisinopril—dilated cardiomyopathy	8.59e-05	0.0359	CcSEcCtD
Metyrapone—CYP11B2—Metabolism—TAZ—dilated cardiomyopathy	8.58e-05	0.00645	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.38e-05	0.0063	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.38e-05	0.0063	CbGpPWpGaD
Metyrapone—Dizziness—Spironolactone—dilated cardiomyopathy	8.34e-05	0.0348	CcSEcCtD
Metyrapone—Vomiting—Spironolactone—dilated cardiomyopathy	8.02e-05	0.0335	CcSEcCtD
Metyrapone—Headache—Spironolactone—dilated cardiomyopathy	7.9e-05	0.033	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—ANKRD1—dilated cardiomyopathy	7.87e-05	0.00591	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.79e-05	0.00586	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SDHA—dilated cardiomyopathy	7.76e-05	0.00583	CbGpPWpGaD
Metyrapone—Nausea—Spironolactone—dilated cardiomyopathy	7.49e-05	0.0313	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—TAZ—dilated cardiomyopathy	7.4e-05	0.00556	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	7.11e-05	0.0297	CcSEcCtD
Metyrapone—Nervous system disorder—Furosemide—dilated cardiomyopathy	6.73e-05	0.0281	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—SDHA—dilated cardiomyopathy	6.69e-05	0.00503	CbGpPWpGaD
Metyrapone—Skin disorder—Furosemide—dilated cardiomyopathy	6.66e-05	0.0278	CcSEcCtD
Metyrapone—Angiopathy—Lisinopril—dilated cardiomyopathy	6.57e-05	0.0274	CcSEcCtD
Metyrapone—Hypotension—Furosemide—dilated cardiomyopathy	6.41e-05	0.0268	CcSEcCtD
Metyrapone—Alopecia—Lisinopril—dilated cardiomyopathy	6.4e-05	0.0267	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	5.92e-05	0.0247	CcSEcCtD
Metyrapone—Pain—Furosemide—dilated cardiomyopathy	5.87e-05	0.0245	CcSEcCtD
Metyrapone—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	5.66e-05	0.00426	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	5.61e-05	0.0234	CcSEcCtD
Metyrapone—Abdominal pain—Furosemide—dilated cardiomyopathy	5.42e-05	0.0226	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	5.33e-05	0.0223	CcSEcCtD
Metyrapone—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	5.33e-05	0.004	CbGpPWpGaD
Metyrapone—Skin disorder—Lisinopril—dilated cardiomyopathy	5e-05	0.0209	CcSEcCtD
Metyrapone—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	4.82e-05	0.00362	CbGpPWpGaD
Metyrapone—Hypotension—Lisinopril—dilated cardiomyopathy	4.81e-05	0.0201	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.73e-05	0.00356	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.61e-05	0.00347	CbGpPWpGaD
Metyrapone—Dizziness—Furosemide—dilated cardiomyopathy	4.54e-05	0.0189	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	4.44e-05	0.0185	CcSEcCtD
Metyrapone—Pain—Lisinopril—dilated cardiomyopathy	4.4e-05	0.0184	CcSEcCtD
Metyrapone—Vomiting—Furosemide—dilated cardiomyopathy	4.36e-05	0.0182	CcSEcCtD
Metyrapone—Headache—Furosemide—dilated cardiomyopathy	4.3e-05	0.0179	CcSEcCtD
Metyrapone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	4.21e-05	0.0176	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.15e-05	0.00312	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.08e-05	0.00307	CbGpPWpGaD
Metyrapone—Nausea—Furosemide—dilated cardiomyopathy	4.07e-05	0.017	CcSEcCtD
Metyrapone—Abdominal pain—Lisinopril—dilated cardiomyopathy	4.07e-05	0.017	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.97e-05	0.00299	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.58e-05	0.00269	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	3.55e-05	0.00267	CbGpPWpGaD
Metyrapone—Dizziness—Lisinopril—dilated cardiomyopathy	3.4e-05	0.0142	CcSEcCtD
Metyrapone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	3.34e-05	0.00251	CbGpPWpGaD
Metyrapone—Vomiting—Lisinopril—dilated cardiomyopathy	3.27e-05	0.0137	CcSEcCtD
Metyrapone—Headache—Lisinopril—dilated cardiomyopathy	3.22e-05	0.0135	CcSEcCtD
Metyrapone—Nausea—Lisinopril—dilated cardiomyopathy	3.06e-05	0.0128	CcSEcCtD
Metyrapone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	3.02e-05	0.00227	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.94e-05	0.00221	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.86e-05	0.00215	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	2.8e-05	0.00211	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	2.64e-05	0.00198	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.58e-05	0.00194	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	2.38e-05	0.00179	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPX1—dilated cardiomyopathy	2.11e-05	0.00158	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CD36—dilated cardiomyopathy	2.05e-05	0.00154	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AGT—dilated cardiomyopathy	1.85e-05	0.00139	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPX1—dilated cardiomyopathy	1.82e-05	0.00137	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	0.00133	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.7e-05	0.00128	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	0.0012	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	1.31e-05	0.000984	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.3e-05	0.000978	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000958	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.22e-05	0.000919	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AGT—dilated cardiomyopathy	1.15e-05	0.000862	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.11e-05	0.000832	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	8.2e-06	0.000616	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	7.98e-06	0.0006	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	7.19e-06	0.00054	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	6.48e-06	0.000487	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	6.31e-06	0.000474	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	5.68e-06	0.000427	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.01e-06	0.000226	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.93e-06	0.00022	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.64e-06	0.000198	CbGpPWpGaD
